Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DCC-3084 |
Trade Name | |
Synonyms | DCC 3084|DCC3084 |
Drug Descriptions |
DCC-3084 is a switch control inhibitor targeting class 1, 2, and 3 BRAF mutations, fusions, and BRAF/CRAF heterodimers, which potentially inhibits Mapk signaling, proliferation, and tumor growth (Cancer Res (2023) 83 (7_Supplement): 4045). |
DrugClasses | BRAF Inhibitor 25 CRAF Inhibitor 12 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DCC-3084 | DCC-3084 | 4 | 1 |